November

Online group therapy may be effective treatment for bulimia nervosa
Study led by UNC researchers compared group therapy delivered via online chat to face-to-face group therapy
Study raises concerns about timely follow-up to positive mammogram for the uninsured
In the journal Cancer Epidemiology, Biomarkers & Prevention, researchers report that uninsured women under age 65 who received their mammogram at community screening clinics in North Carolina were less likely to get follow-up within a year of a positive mammogram, and had higher odds of missing a 60-day window for follow-up care.
Could targeting a gene linked to microcephaly lead to a better brain cancer treatment?
UNC Lineberger researchers led by Dr. Timothy R. Gershon report preclinical findings showing promise for targeting a gene linked to microcephaly in infants as a treatment for medulloblastoma.
UNC scientists identify “collateral vessel” gene that protects against stroke damage
Variants of the human version of the gene may help explain why people differ so much in their ability to survive artery blockages.
Visitor restrictions begin Nov. 14 for children under 12 in NCCC, PICU, BMTU at UNC Hospitals
To ensure the safety of our patients, visitor restrictions for children under 12 (age 11 years old and younger) will go into effect Monday, Nov. 14, 2016, for the Newborn Critical Care Center (NCCC), Pediatric Intensive Care Unit (PICU), and Bone Marrow Transplant Unit (BMTU) at UNC Hospitals.
UNC scientists named to European Union-funded global Zika research consortium
The UNC School of Medicine was one of two U.S. institutions named to an international research consortium funded through the European Union’s Horizon 2020 Programme, which invested $49 million in Zika research and vaccine development at more than 20 laboratories in Europe and Brazil.
Researching the Receptors
At this year’s Smithies Nobel Symposium lecture, Stanford’s Brian Kobilka spoke on the importance of GPCRs in drug development.
Tracing the Development of Neurons
Stephanie Gupton, PhD, was recently awarded a Jefferson-Pilot Fellowship Award for her research into how neurons change shape and mature during development. We sat down with her for Five Questions.
Changing Course, Finding a Home
From his position as a transfusion medicine physician, Jay Raval, MD, collaborates with providers from across UNC Medical Center to coordinate the best treatments for patients, while also giving him the chance to study ways to improve that care. His efforts have earned him this year’s Woods Junior Faculty Award.
Following the ‘Tinman’
Inspired by a genetic discovery by her PhD mentor, UNC heart researcher Li Qian followed the ‘Tinman’ down the yellow brick road to an award-winning career in science, including the Jefferson-Pilot Fellowship in Academic Medicine.
It’s how you splice it: scientists discover possible origin of muscle, heart defects
The basic biological process called alternative splicing proves vital in making sure important muscle cell proteins switch from their fetal forms to their adult forms. Not doing so could lead to muscle defects and disorders.
Celebrating Student Research
On Nov. 11, the UNC School of Medicine celebrated the 48th annual Student Research Day, hosted by the John B. Graham Student Research Society.
‘Unraveling Zika’: Join UNC School of Medicine experts for panel discussion, Q&A
The UNC School of Medicine has more than a dozen groups dedicated to Zika research and vaccine development. On Tuesday, Nov. 29, the School of Medicine will host an expert panel event and Q&A discussion in the Nelson Mandela Auditorium at UNC’s FedEx Global Education Center. The event is open to the public and audience questions are encouraged.
HPDP receives $1.5 million to develop diabetes self-management education toolkit
Dr. Thomas Keyserling and Dr. Greg Randolph from the UNC School of Medicine are investigators in the project.
Can nanotechnology help develop a workable dengue virus vaccine?
UNC School of Medicine researchers Aravinda de Silva, PhD, professor of microbiology and immunology, and Stefan Metz, PhD, are creating a nanoparticle vaccine that in experiments showed increased antibody responses against one serotype of dengue virus. The de Silva group is collaborating with the UNC laboratories of Chris Luft, PhD, (pharmacy and chemistry), Jenny Ting, PhD, (genetics), and Mike Miley,PhD, (pharmacology), as well as Liquidia Pharmaceuticals to use the same nanoparticle platform to develop a vaccine for all four serotypes of the virus.
UNC's Dr. Sidney Smith receives two major AHA awards
This is the first time that the American Heart Association (AHA) has presented two major awards to one recipient.
UNC researchers find that Malaria parasite evades rapid test detection in children
A study at the University of North Carolina found that gene deletion poses a threat to Malaria eradication efforts.
Flavors influence appeal and use of most tobacco products, especially for youth
UNC Lineberger researchers led by Adam Goldstein, MD, MPH, concluded in a study published in Tobacco Control that banning non-menthol flavors like fruit and candy could reduce use of most tobacco products across the globe, especially among adolescents.
A miracle for the Millers
As survivability of many cancers increases, so does the opportunity to help survivors live the lives they’d imagined. Manda Miller thought bouts of Hodgkins Lymphoma at 19 and 27 had taken her chance to have children, but Jennifer Mersereau, MD, at UNC Fertility offered an innovative option for the Millers' miracle baby — a donor egg.
UNC clinical trials play crucial role in FDA approval for diabetes drug
Led by John Buse, MD, PhD, director of the UNC Diabetes Care Center, the clinical research of UNC doctors and the participation of thousands of patients culminates in a new, effective, and safe daily injectable drug to combat type-2 diabetes.
Can a smart patch prevent blood clots?
In lab experiments, North Carolina researchers developed the first patch to monitor blood viscosity and release blood thinning medication as needed.
Share This: